Loading stock data...
107380038 17091621382024 01 08t222259z 438997219 rc2yd5adt2v5 rtrmadp 0 tech ai

C3 AI tumbles 26% as CEO Siebel calls preliminary sales numbers ‘completely unacceptable’ amid restructuring

Shares of C3 AI declined sharply, ending the session about 26% lower after the company unveiled a set of preliminary financial results and confirmed a broad overhaul of its global sales and services organization. The move underscored investor concerns about the company’s near-term trajectory as it works through a restructuring that management has described as disruptive to the core sales engine. The headline figures the company disclosed point to a softer start to fiscal first-quarter 2026 than a year earlier, intensifying questions about how the company will restore growth while absorbing the costs and disruption associated with the organizational changes. In the specifics, C3 AI guided revenue for the quarter to come in a range of $70.2 million to $70.4 million, with the caveat that these numbers are unaudited and preliminary. By comparison, the company reported $87.2 million in revenue in the same quarter a year ago, highlighting a meaningful year-over-year decline in top-line performance even before considering the impact of the restructuring and any related operating costs.

This revenue outlook sits alongside a GAAP loss from operations that is expected to be between $124.7 million and $124.9 million for the quarter, a substantial widening from the loss recorded in the prior year period, which stood at $72.59 million. The disparity between the expected loss and the prior year’s results reflects the dual pressures the company faces: intensifying operating expenses tied to the reorganization, and a lower revenue base that cannot fully offset these costs in the near term. The market reaction to these preliminary results underscores investors’ concern that the combination of a heavy restructuring burden and a softer revenue path could dampen near-term profitability and slow the path back to sustainable growth. As the company framed the guidance, the numbers are early estimates, and the company noted that the figures are unaudited, leaving room for subsequent revisions as the quarter unfolds and the sales organization continues to operate under the new structure.

Chief Executive Officer Tom Siebel characterized the quarterly performance as “completely unacceptable,” a stark assessment that foreshadowed a broader conversation about the company’s sales strategy and execution. He attributed the disappointing results in part to the disruptive effect of the ongoing reorganization of the sales and services framework, which was designed to realign how the company engages with customers, deploys resources, and integrates service delivery across regions. In his statement, Siebel suggested that the headwinds from the reorganization had impeded the company’s sales velocity, potentially limiting the ability of the sales team to close deals with the same urgency and efficiency as before. He further noted that his own health-related constraints during the period may have reduced his capacity to participate actively in the sales process, which he implied could have amplified the impact of the restructuring on sales outcomes.

Siebel had disclosed in July that he had been diagnosed with an autoimmune disease earlier in the year, a condition that had led to significant visual impairment. His disclosure added a human dimension to the discussion around leadership and execution, casting recent results in the context of personal health challenges that have affected his ability to oversee the sales organization in a hands-on manner. The disclosure also helped explain in part why the company’s board and Siebel decided to initiate a search for the organization’s next chief executive, seeking to balance the need for strong leadership with the practical realities of Siebel’s own health situation. In the present update, the board and Siebel together announced that the company’s sales and services restructuring has been completed. Siebel stated that his health has “improved dramatically,” with vision impairment remaining a challenge but not preventing him from remaining engaged and focused on guiding the strategic transition. He added that he is feeling strong and fully engaged and pledged to move quickly to identify “excellent” CEO candidates who could help drive accelerated growth and operational excellence in the company’s next phase.

In the context of leadership and governance, Siebel affirmed that the process to identify the next chief executive is underway, with the board and management actively pursuing a smooth transition plan. This comes as the company’s leadership acknowledges that a refreshed executive team can be a critical factor in executing the reorganization while maintaining continuity for customers, partners, and employees. Siebel’s remarks suggested a sense of optimism about the company’s strategic position, even as he recognized the ongoing need to deliver improved results and to restore confidence among investors and clients that C3 AI can regain momentum in a highly competitive AI software market. The company scheduled a conference call to discuss its first-quarter results on Sept. 3 at 5 p.m. Eastern Time, signaling its intent to provide a more comprehensive update on the financials, the impact of the reorganization, and the path forward for leadership and growth.

The broader implications of the results and the leadership transition extend beyond the quarter at hand. The combination of a lower revenue outlook and a wider GAAP loss from operations suggests that the company is still navigating the monetary and operational challenges associated with restructuring. The reorganization, described by Siebel as complete, represents a strategic pivot intended to sharpen the company’s go-to-market approach, potentially alter incentive structures, and streamline the delivery of services to customers. However, the immediate implication is an elevated cost base and a period of adjustment as the sales teams adapt to new roles, targets, and processes. The market will be watching to see whether the new framework can translate into stronger deal velocity, higher win rates, and more favorable operating margins over the medium term, and whether the leadership transition can deliver a steady hand to guide the company through this transitional phase.

As investors parse the news, attention is likely to focus on several key questions: Will the anticipated revenue decline reverse in the coming quarters as the reorganized sales and services engine matures and gains traction with customers? Can the company manage the higher operating losses while investments in growth and restructured capabilities begin to pay off? How will a new CEO shape the company’s strategic priorities, partner ecosystems, and customer engagements during a period of AI market volatility and heightened competition? And how will Siebel’s health situation influence his ability to oversee the company’s strategy and execution during the transition to new leadership? The answers to these questions will shape how investors value C3 AI in the near term and how the company positions itself within the broader enterprise AI landscape.

The company’s announcement did not stand in isolation from other market dynamics. The AI software space has seen a mix of optimism about long-term growth and scrutiny about the near-term profitability of numerous AI software developers, especially those with substantial restructuring needs or those investing aggressively to scale their go-to-market engines. In this environment, C3 AI’s decision to undertake a comprehensive reorganization of its global sales and services network—paired with a candid acknowledgment of the health challenges faced by its CEO—adds a nuanced layer to its narrative. The market response suggests that investors are weighing the potential for a more streamlined, efficiency-focused sales operation against the risk that the near-term financials will remain soft as the organizational changes take root. The forthcoming conference call is expected to provide further clarity on timing, milestones, and the execution plan for the sales reorganization as well as for the leadership transition, including any interim steps the company might take to stabilize the business while the management team and board pursue a long-term strategy.

This combination of restructuring, a softer revenue forecast, and a widening GAAP loss underscores the delicate balancing act that C3 AI must perform as it works to return to sustainable growth. While the company acknowledges the progress it has made in completing the reorganization, the path forward will depend on how quickly the redesigned sales and services framework can translate into improved deal flow, higher customer retention, and better operating leverage. The leadership shift, while potentially disruptive in the short term, may position C3 AI to attract a CEO with a sharper focus on go-to-market execution, strategic partnerships, and scalable enterprise deployments—critical components for winning larger, more predictable contracts in a competitive AI market.

Finally, the timing of the conference call will provide a critical forum for management to expand on the preliminary numbers, explain the assumptions behind the revenue guidance, and outline the steps being taken to ensure the restructuring translates into tangible improvements in the company’s operating performance. Analysts and investors will be listening for updates on customer engagement metrics, sales cycle dynamics, backlog development, and the expected duration of the impact from the reorganization. They will also look for any additional color on the status of the CEO search, the envisioned leadership profile, and how the board plans to maintain continuity through the transition. In sum, while the near-term numbers suggest ongoing headwinds, the company’s long-term strategy remains centered on establishing a more effective enterprise AI platform and a reoriented, high-performing global sales and services operation under new leadership.

Conclusion: C3 AI’s latest disclosures illuminate a company at a crossroads, balancing a calculated structural change with personal health challenges faced by its chief executive and a market that is closely watching the pace at which the reorganized sales engine can deliver meaningful revenue and profit improvements. The revenue guidance for the upcoming quarter points to a slower start as the organization absorbs the costs and adjusts to the new go-to-market framework, while the expanded GAAP loss underscores the near-term burden of restructuring and strategic investments. Siebel’s acknowledgment of the health issues that constrained his involvement and the board’s initiation of a search for a new CEO reflect an understanding that leadership depth and continuity will be essential to accelerating progress. As the company prepares for its conference call and lays out its roadmap, investors will be paying close attention to how quickly the sales reorganization yields tangible improvements, how the leadership transition unfolds, and whether early indicators begin to point toward a return to growth in the face of a competitive AI market. The coming quarters will be telling as C3 AI seeks to translate structural changes into improved outcomes, reinforce confidence among customers and partners, and establish a sustainable path toward profitability through disciplined execution and strategic leadership.